|
시장보고서
상품코드
1786785
세계의 소아 당뇨병 치료 시장 : 규모, 점유율, 동향, 산업 분석 보고서 - 유형별, 치료별, 투여 경로별, 용도별, 유통 채널별, 지역별 시장 예측(2025-2034년)Pediatric Diabetes Therapeutic Market Size, Share, Trends, & Industry Analysis Report By Type (Type 1, Type 2), By Therapy, By Route of Administration, By Application, By Distribution Channel, and By Region - Market Forecast, 2025-2034 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Polaris Market Research의 최근 조사에 따르면 소아 당뇨병 치료 시장 규모는 2034년까지 346억 달러에 이를 것으로 예측됩니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.
소아 당뇨병 치료에는 인슐린 요법, 경구 항당뇨병 약물, GLP-1 수용체 작용제, 1형 및 2형 당뇨병으로 진단된 소아 및 청소년을 위해 설계된 디지털 포도당 모니터링 기술 등이 포함됩니다. 이 시장은 디지털 치료제, 통합형 인슐린 전달 시스템, 실시간 포도당 모니터링 플랫폼의 채용 증가로 현저한 변모를 이루고 있습니다.
시장 성장의 주요 요인은 소아의 1형 당뇨병 이환율 증가, 조기 발병 2형 당뇨병 진단 증가, 원격 모니터링 및 디지털 치료 플랫폼의 통합 증가입니다. 소아에 특화된 인슐린 전달 시스템의 개발 진전과 비인슐린 요법에 대한 규제 당국의 승인 확대가 선진 및 신흥 지역에서의 치료 편의성과 시장 확대에 기여하고 있습니다.
소아 당뇨병 치료 시장 보고서 하이라이트
유형별로는 소아 집단에서 높은 유병률 및 평생에 걸친 인슐린 요법의 필요성 때문에 2024년에 1형 부문이 최대 점유율을 차지했습니다.
치료별로는 인슐린 치료 분야가 2024년 시장을 독점했습니다. 이는 소아 당뇨병 치료에 있어서 중요한 역할과 스마트 및 디지털 통합형 전달 시스템의 채용 확대 때문입니다.
투여 경로별로, 임상 및 재택 환경에서의 인슐린 주사 및 스마트 전달 시스템의 보급으로 비경구 투여 부문이 2024년에 가장 큰 시장 점유율을 차지했습니다.
용도별로는 소아의 1형 당뇨병과 진행된 2형 당뇨병의 주요 치료제인 인슐린 제제가 2024년 시장을 독점했습니다.
유통 채널에서 병원 부문은 2024년 시장을 독점했습니다. 이것은 많은 진단 건수 및 선진 치료에 대한 액세스가 배경에 있습니다.
북미는 구조화된 소아 내분비 의료 및 디지털 당뇨병 관리 기술의 조기 도입에 힘입어 2024년 세계 소아 당뇨병 치료 시장에서 대부분의 점유율을 차지했습니다.
아시아태평양은 소아 당뇨병 환자 증가 및 정부의 의료 투자로 예측 기간 동안 크게 성장할 전망입니다.
세계 주요 시장 기업으로는 Novo Nordisk A/S, Sanofi, Eli Lilly and Company, Medtronic plc, Abbott Laboratories, F. Hoffmann-La Roche Ltd, Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Ascensia Diahartes Care Holdings AG, Glenmark Pharmaceuticals Ltd., Biocon Limited 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 소아 당뇨병 치료 시장 인사이트
- 시장 현황
- 소아 당뇨병 치료 시장 역학
- 성장 촉진요인 및 기회
- 세계 소아에서 1형 당뇨병 발병률 상승
- 원격 모니터링 및 디지털 치료 도입 확대
- 성장 억제요인 및 과제
- 고액의 치료비 및 접근의 제한
- 성장 촉진요인 및 기회
- PESTEL 분석
- 소아 당뇨병 치료 시장 동향
- 밸류체인 분석
제5장 세계의 소아 당뇨병 치료 시장 : 유형별
- 주요 조사 결과
- 서문
- 1형
- 2형
제6장 세계의 소아 당뇨병 치료 시장 : 치료별
- 주요 조사 결과
- 서문
- 약물 요법
- 인슐린 요법
제7장 세계의 소아 당뇨병 치료 시장 : 투여 경로별
- 주요 조사 결과
- 서문
- 경구 투여
- 비강 투여
- 비경구 투여
제8장 세계의 소아 당뇨병 치료 시장 : 용도별
- 주요 조사 결과
- 서문
- 인슐린
- GLP-1 수용체 작용제
- 비구아니드
- SGLT2 억제제
- 기타
제9장 세계의 소아 당뇨병 치료 시장 : 유통 채널별
- 주요 조사 결과
- 서문
- 병원
- 전문 클리닉
- 소매 약국
- 약국
제10장 세계의 소아 당뇨병 치료 시장 : 지역별
- 주요 조사 결과
- 서문
- 소아 당뇨병 치료 시장 평가 : 지역별(2020-2034년)
- 북미
- 북미 : 유형별(2020-2034년)
- 북미 : 치료별(2020-2034년)
- 북미 : 투여 경로별(2020-2034년)
- 북미 : 용도별(2020-2034년)
- 북미 : 유통 채널별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 유형별(2020-2034년)
- 유럽 : 치료별(2020-2034년)
- 유럽 : 투여 경로별(2020-2034년)
- 유럽 : 용도별(2020-2034년)
- 유럽 : 유통 채널별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 유형별(2020-2034년)
- 아시아태평양 : 치료별(2020-2034년)
- 아시아태평양 : 투여 경로별(2020-2034년)
- 아시아태평양 : 용도별(2020-2034년)
- 아시아태평양 : 유통 채널별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 유형별(2020-2034년)
- 중동 및 아프리카 : 치료별(2020-2034년)
- 중동 및 아프리카 : 투여 경로별(2020-2034년)
- 중동 및 아프리카 : 용도별(2020-2034년)
- 중동 및 아프리카 : 유통 채널별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 유형별(2020-2034년)
- 라틴아메리카 : 치료별(2020-2034년)
- 라틴아메리카 : 투여 경로별(2020-2034년)
- 라틴아메리카 : 용도별(2020-2034년)
- 라틴아메리카 : 유통 채널별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제11장 경쟁 구도
- 확대 및 인수 분석
- 확대
- 인수
- 제휴, 협업, 합의 및 공개
제12장 기업 프로파일
- Abbott Laboratories
- Ascensia Diabetes Care Holdings AG
- Biocon Limited
- Dexcom Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd
- Glenmark Pharmaceuticals Ltd.
- Insulet Corporation
- Medtronic plc
- Novo Nordisk A/S
- Sanofi
- Tandem Diabetes Care Inc.
The pediatric diabetes therapeutics market size is expected to reach USD 34.60 Billion by 2034, according to a new study by Polaris Market Research. The report "Pediatric Diabetes Therapeutic Market Size, Share, Trends, & Industry Analysis Report By Type (Type 1, Type 2), By Therapy, By Route of Administration, By Application, By Distribution Channel, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Pediatric diabetes therapeutics include insulin therapies, oral antidiabetic drugs, GLP-1 receptor agonists and digital glucose monitoring technologies designed for children and adolescents diagnosed with type 1 and type 2 diabetes. The market is witnessing significant transformation through increased adoption of digital therapeutics, integrated insulin delivery systems, and real-time glucose monitoring platforms.
Market growth is primarily driven by the rising incidence of type 1 diabetes among children, growing diagnosis of early-onset type 2 diabetes and increasing integration of remote monitoring and digital therapeutic platforms. Growing advancements in pediatric-specific insulin delivery systems and expanding regulatory approvals for non-insulin therapies are contributing to treatment accessibility and market expansion across developed and emerging regions.
Pediatric Diabetes Therapeutic Market Report Highlights
Based on type, the type 1 segment accounted for largest share in 2024, due to high prevalence and the requirement for lifelong insulin therapy in pediatric populations.
In terms of therapy, the insulin therapy segment dominated the market in 2024. This is driven by its key role in pediatric diabetes care and growing adoption of smart & digitally integrated delivery systems.
Based on route of administration, the parenteral administration segment held the largest market share in 2024 due to its widespread adoption of insulin injections and smart delivery systems in clinical and home settings.
Based on application, the insulin segment dominated the market in 2024, as it remains the primary treatment for pediatric type 1 diabetes and advanced type 2 cases.
In terms of distribution channel, the hospitals segment dominated the market in 2024. This is fueled by high diagnosis volume and access to advanced therapies.
North America accounted for the majority share in the global pediatric diabetes therapeutic market in 2024, fueled by fueled by structured pediatric endocrinology care and early adoption of digital diabetes management technologies.
Asia Pacific is expected to grow significantly during the forecast period, fueled by increasing childhood diabetes cases and government healthcare investments.
A few global key market players include Novo Nordisk A/S, Sanofi, Eli Lilly and Company, Medtronic plc, Abbott Laboratories, F. Hoffmann-La Roche Ltd, Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Ascensia Diabetes Care Holdings AG, Glenmark Pharmaceuticals Ltd., and Biocon Limited.
Polaris Market Research has segmented the market report on the basis of type, therapy, route of administration, application, distribution channel, and region:
By Type Outlook (Revenue, USD Billion, 2020-2034)
Type 1
Type 2
By Therapy Outlook (Revenue, USD Billion, 2020-2034)
Drug Therapy
Biguanide
Sodium-glucose co-transporter 2 (SGLT2) inhibitors
Insulin Therapy
Rapid-acting Insulin
Short-acting Insulin
Intermediate-acting Insulin
Long-acting Insulin
By Route of Administration Outlook (Revenue, USD Billion, 2020-2034)
Oral Administration
Nasal Administration
Parenteral Administration
Subcutaneous
Intramuscular
Intravenous
By Application Outlook (Revenue, USD Billion, 2020-2034)
Insulin
GLP-1 Receptor Agonists
Biguanide
SGLT2 Inhibitors
Other Application
By Distribution Channel Outlook (Revenue, USD Billion, 2020-2034)
Hospitals
Specialty Clinics
Retail Pharmacies
Drug Stores
By Regional Outlook (Revenue, USD Billion, 2020-2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Pediatric Diabetes Therapeutic Market Insights
- 4.1. Pediatric Diabetes Therapeutic Market - Market Snapshot
- 4.2. Pediatric Diabetes Therapeutic Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Incidence of Type 1 Diabetes in Children Globally
- 4.2.1.2. Growing Adoption of Remote Monitoring and Digital Therapeutics
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Treatment Costs and Limited Access
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Pediatric Diabetes Therapeutic Market Trends
- 4.6. Value Chain Analysis
5. Global Pediatric Diabetes Therapeutic Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 5.3. Type 1
- 5.3.1. Global Pediatric Diabetes Therapeutic Market, by Type 1, by Region, 2020-2034 (USD Billion)
- 5.4. Type 2
- 5.4.1. Global Pediatric Diabetes Therapeutic Market, by Type 2, by Region, 2020-2034 (USD Billion)
6. Global Pediatric Diabetes Therapeutic Market, by Therapy
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 6.3. Drug Therapy
- 6.3.1. Global Pediatric Diabetes Therapeutic Market, by Drug Therapy, by Region, 2020-2034 (USD Billion)
- 6.4. Insulin Therapy
- 6.4.1. Global Pediatric Diabetes Therapeutic Market, by Insulin Therapy, by Region, 2020-2034 (USD Billion)
7. Global Pediatric Diabetes Therapeutic Market, by Route of Administration
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 7.3. Oral Administration
- 7.3.1. Global Pediatric Diabetes Therapeutic Market, by Oral Administration, by Region, 2020-2034 (USD Billion)
- 7.4. Nasal Administration
- 7.4.1. Global Pediatric Diabetes Therapeutic Market, by Nasal Administration, by Region, 2020-2034 (USD Billion)
- 7.5. Parenteral Administration
- 7.5.1. Global Pediatric Diabetes Therapeutic Market, by Parenteral Administration, by Region, 2020-2034 (USD Billion)
8. Global Pediatric Diabetes Therapeutic Market, by Application
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 8.3. Insulin
- 8.3.1. Global Pediatric Diabetes Therapeutic Market, by Insulin, by Region, 2020-2034 (USD Billion)
- 8.4. GLP-1 Receptor Agonists
- 8.4.1. Global Pediatric Diabetes Therapeutic Market, by GLP-1 Receptor Agonists, by Region, 2020-2034 (USD Billion)
- 8.5. Biguanide
- 8.5.1. Global Pediatric Diabetes Therapeutic Market, by Biguanide, by Region, 2020-2034 (USD Billion)
- 8.6. SGLT2 Inhibitors
- 8.6.1. Global Pediatric Diabetes Therapeutic Market, by SGLT2 Inhibitors, by Region, 2020-2034 (USD Billion)
- 8.7. Other Application
- 8.7.1. Global Pediatric Diabetes Therapeutic Market, by Other Application, by Region, 2020-2034 (USD Billion)
9. Global Pediatric Diabetes Therapeutic Market, by Distribution Channel
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Global Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.3. Hospitals
- 9.3.1. Global Pediatric Diabetes Therapeutic Market, by Hospitals, by Region, 2020-2034 (USD Billion)
- 9.4. Specialty Clinics
- 9.4.1. Global Pediatric Diabetes Therapeutic Market, by Specialty Clinics, by Region, 2020-2034 (USD Billion)
- 9.5. Retail Pharmacies
- 9.5.1. Global Pediatric Diabetes Therapeutic Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)
- 9.6. Drug Stores
- 9.6.1. Global Pediatric Diabetes Therapeutic Market, by Drug Stores, by Region, 2020-2034 (USD Billion)
10. Global Pediatric Diabetes Therapeutic Market, by Geography
- 10.1. Key Findings
- 10.2. Introduction
- 10.2.1. Pediatric Diabetes Therapeutic Market Assessment, By Geography, 2020-2034 (USD Billion)
- 10.3. Pediatric Diabetes Therapeutic Market - North America
- 10.3.1. North America: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.3.2. North America: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.3.3. North America: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.3.4. North America: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.3.5. North America: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.3.6. Pediatric Diabetes Therapeutic Market - U.S.
- 10.3.6.1. U.S.: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.3.6.2. U.S.: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.3.6.3. U.S.: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.3.6.4. U.S.: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.3.6.5. U.S.: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.3.7. Pediatric Diabetes Therapeutic Market - Canada
- 10.3.7.1. Canada: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.3.7.2. Canada: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.3.7.3. Canada: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.3.7.4. Canada: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.3.7.5. Canada: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.4. Pediatric Diabetes Therapeutic Market - Europe
- 10.4.1. Europe: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.4.2. Europe: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.4.3. Europe: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.4. Europe: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.4.5. Europe: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.4.6. Pediatric Diabetes Therapeutic Market - UK
- 10.4.6.1. UK: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.4.6.2. UK: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.4.6.3. UK: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.6.4. UK: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.4.6.5. UK: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.4.7. Pediatric Diabetes Therapeutic Market - France
- 10.4.7.1. France: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.4.7.2. France: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.4.7.3. France: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.7.4. France: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.4.7.5. France: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.4.8. Pediatric Diabetes Therapeutic Market - Germany
- 10.4.8.1. Germany: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.4.8.2. Germany: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.4.8.3. Germany: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.8.4. Germany: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.4.8.5. Germany: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.4.9. Pediatric Diabetes Therapeutic Market - Italy
- 10.4.9.1. Italy: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.4.9.2. Italy: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.4.9.3. Italy: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.9.4. Italy: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.4.9.5. Italy: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.4.10. Pediatric Diabetes Therapeutic Market - Spain
- 10.4.10.1. Spain: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.4.10.2. Spain: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.4.10.3. Spain: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.10.4. Spain: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.4.10.5. Spain: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.4.11. Pediatric Diabetes Therapeutic Market - Netherlands
- 10.4.11.1. Netherlands: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.4.11.2. Netherlands: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.4.11.3. Netherlands: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.11.4. Netherlands: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.4.11.5. Netherlands: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.4.12. Pediatric Diabetes Therapeutic Market - Russia
- 10.4.12.1. Russia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.4.12.2. Russia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.4.12.3. Russia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.12.4. Russia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.4.12.5. Russia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.4.13. Pediatric Diabetes Therapeutic Market - Rest of Europe
- 10.4.13.1. Rest of Europe: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.4.13.2. Rest of Europe: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.4.13.3. Rest of Europe: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.13.4. Rest of Europe: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.4.13.5. Rest of Europe: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.5. Pediatric Diabetes Therapeutic Market - Asia Pacific
- 10.5.1. Asia Pacific: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.5.2. Asia Pacific: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.5.3. Asia Pacific: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.4. Asia Pacific: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.5.5. Asia Pacific: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.5.6. Pediatric Diabetes Therapeutic Market - China
- 10.5.6.1. China: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.5.6.2. China: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.5.6.3. China: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.6.4. China: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.5.6.5. China: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.5.7. Pediatric Diabetes Therapeutic Market - India
- 10.5.7.1. India: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.5.7.2. India: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.5.7.3. India: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.7.4. India: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.5.7.5. India: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.5.8. Pediatric Diabetes Therapeutic Market - Malaysia
- 10.5.8.1. Malaysia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.5.8.2. Malaysia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.5.8.3. Malaysia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.8.4. Malaysia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.5.8.5. Malaysia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.5.9. Pediatric Diabetes Therapeutic Market - Japan
- 10.5.9.1. Japan: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.5.9.2. Japan: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.5.9.3. Japan: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.9.4. Japan: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.5.9.5. Japan: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.5.10. Pediatric Diabetes Therapeutic Market - Indonesia
- 10.5.10.1. Indonesia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.5.10.2. Indonesia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.5.10.3. Indonesia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.10.4. Indonesia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.5.10.5. Indonesia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.5.11. Pediatric Diabetes Therapeutic Market - South Korea
- 10.5.11.1. South Korea: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.5.11.2. South Korea: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.5.11.3. South Korea: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.11.4. South Korea: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.5.11.5. South Korea: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.5.12. Pediatric Diabetes Therapeutic Market - Australia
- 10.5.12.1. Australia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.5.12.2. Australia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.5.12.3. Australia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.12.4. Australia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.5.12.5. Australia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.5.13. Pediatric Diabetes Therapeutic Market - Rest of Asia Pacific
- 10.5.13.1. Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.5.13.2. Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.5.13.3. Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.13.4. Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.5.13.5. Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.6. Pediatric Diabetes Therapeutic Market - Middle East & Africa
- 10.6.1. Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.6.2. Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.6.3. Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.6.4. Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.6.5. Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.6.6. Pediatric Diabetes Therapeutic Market - Saudi Arabia
- 10.6.6.1. Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.6.6.2. Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.6.6.3. Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.6.6.4. Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.6.6.5. Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.6.7. Pediatric Diabetes Therapeutic Market - UAE
- 10.6.7.1. UAE: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.6.7.2. UAE: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.6.7.3. UAE: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.6.7.4. UAE: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.6.7.5. UAE: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.6.8. Pediatric Diabetes Therapeutic Market - Israel
- 10.6.8.1. Israel: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.6.8.2. Israel: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.6.8.3. Israel: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.6.8.4. Israel: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.6.8.5. Israel: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.6.9. Pediatric Diabetes Therapeutic Market - South Africa
- 10.6.9.1. South Africa: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.6.9.2. South Africa: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.6.9.3. South Africa: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.6.9.4. South Africa: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.6.9.5. South Africa: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.6.10. Pediatric Diabetes Therapeutic Market - Rest of Middle East & Africa
- 10.6.10.1. Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.6.10.2. Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.6.10.3. Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.6.10.4. Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.6.10.5. Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.7. Pediatric Diabetes Therapeutic Market - Latin America
- 10.7.1. Latin America: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.7.2. Latin America: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.7.3. Latin America: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.7.4. Latin America: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.7.5. Latin America: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.7.6. Pediatric Diabetes Therapeutic Market - Mexico
- 10.7.6.1. Mexico: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.7.6.2. Mexico: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.7.6.3. Mexico: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.7.6.4. Mexico: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.7.6.5. Mexico: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.7.7. Pediatric Diabetes Therapeutic Market - Brazil
- 10.7.7.1. Brazil: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.7.7.2. Brazil: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.7.7.3. Brazil: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.7.7.4. Brazil: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.7.7.5. Brazil: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.7.8. Pediatric Diabetes Therapeutic Market - Argentina
- 10.7.8.1. Argentina: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.7.8.2. Argentina: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.7.8.3. Argentina: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.7.8.4. Argentina: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.7.8.5. Argentina: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.7.9. Pediatric Diabetes Therapeutic Market - Rest of Latin America
- 10.7.9.1. Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
- 10.7.9.2. Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
- 10.7.9.3. Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.7.9.4. Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
- 10.7.9.5. Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
11. Competitive Landscape
- 11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
- 11.2. Partnerships/Collaborations/Agreements/Exhibitions
12. Company Profiles
- 12.1. Abbott Laboratories
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
- 12.2. Ascensia Diabetes Care Holdings AG
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
- 12.3. Biocon Limited
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
- 12.4. Dexcom Inc.
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
- 12.5. Eli Lilly and Company
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
- 12.6. F. Hoffmann-La Roche Ltd
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
- 12.7. Glenmark Pharmaceuticals Ltd.
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
- 12.8. Insulet Corporation
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
- 12.9. Medtronic plc
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
- 12.10. Novo Nordisk A/S
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
- 12.11. Sanofi
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development
- 12.12. Tandem Diabetes Care Inc.
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Benchmarking
- 12.12.4. Recent Development
샘플 요청 목록